Chimeric Therapeutics Ltd

NEW
OTCPK:CHMMF (Australia)   Ordinary Shares
$ 0.10 -0.029 (-96.67%) 10:08 PM EST
At Loss
Market Cap:
$ 2.45M
Enterprise V:
$ 2.83M
Volume:
0
Avg Vol (2M):
0
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
0

Business Description

Description
Chimeric Therapeutics Ltd is an Australian clinical-stage cell therapy company focused on developing and commercialising a range of cell therapies in oncology. The group's products under development include T Cell Derived Autologous Therapies and Natural Killer (NK) Cell Derived Allogenic Therapies. T Cell Derived Autologous therapy works by engineering the T cells with the exact coordinates to attack and kill cancer. NK Cell Derived Allogenic Therapies from healthy donors can be manufactured on a large scale and, once administered, kill cancer. Its pipeline products include CDH17, CLTX, and CORE NK. The group has one reportable segment, being the research, development, and commercialisation of health technologies.
Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
-0.51
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-6.44
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.69
Quick Ratio
0.69
Cash Ratio
0.34
Days Sales Outstanding
8
Days Payable
2104.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-65.3
Shareholder Yield %
-229.32
Name Current Vs Industry Vs History
Gross Margin %
78.66
Operating Margin %
-380.73
Net Margin %
-262.79
EBITDA Margin %
-228.7
FCF Margin %
-221.56
OCF Margin %
-215.33
ROE %
-1153.64
ROA %
-122.06
ROIC %
-98.83
3-Year ROIIC %
-132.25
ROC (Joel Greenblatt) %
-1846900
ROCE %
-397.04

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio
0.22
EV-to-EBIT
-0.22
EV-to-Forward-EBIT
-0.86
EV-to-EBITDA
-0.22
EV-to-Forward-EBITDA
-0.71
EV-to-Revenue
1.03
EV-to-FCF
-0.47
Earnings Yield (Greenblatt) %
-454.55
FCF Yield %
-244.87

Financials

CHMMF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CHMMF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Chimeric Therapeutics Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.584
EPS (TTM) ($) -0.554
Beta 1.9206
3-Year Sharpe Ratio 0.1
3-Year Sortino Ratio 0.18
Volatility % -
14-Day RSI -
14-Day ATR ($) -
20-Day SMA ($) 0.1
12-1 Month Momentum % -
52-Week Range ($) 0.1 - 0.1
Shares Outstanding (Mil) 54.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Chimeric Therapeutics Ltd Filings

Filing Date Document Date Form
No Filing Data

Chimeric Therapeutics Ltd Stock Events

Financials Calendars
Event Date Price ($)
0.01:1 Stock Split 2026-04-22 0.10 (+0.00%)
Show
Entries

Chimeric Therapeutics Ltd Frequently Asked Questions

What is Chimeric Therapeutics Ltd(CHMMF)'s stock price today?
The current price of CHMMF is $0.10. The 52 week high of CHMMF is $0.10 and 52 week low is $0.10.
When is next earnings date of Chimeric Therapeutics Ltd(CHMMF)?
The next earnings date of Chimeric Therapeutics Ltd(CHMMF) is .
Does Chimeric Therapeutics Ltd(CHMMF) pay dividends? If so, how much?
Chimeric Therapeutics Ltd(CHMMF) does not pay dividend.

Guru Commentaries on OTCPK:CHMMF

No articles.

Articles on Chimeric Therapeutics Ltd

No articles.

Headlines

See More
  • 1
No news.
  • 1